0001567619-21-011167.txt : 20210525 0001567619-21-011167.hdr.sgml : 20210525 20210525184442 ACCESSION NUMBER: 0001567619-21-011167 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210521 FILED AS OF DATE: 20210525 DATE AS OF CHANGE: 20210525 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bickerstaff George CENTRAL INDEX KEY: 0001329646 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 21962203 MAIL ADDRESS: STREET 1: C/O VION PHARMACEUTICALS, INC. STREET 2: 4 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Innoviva, Inc. CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1350 OLD BAYSHORE HIGHWAY STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 6502389600 MAIL ADDRESS: STREET 1: 1350 OLD BAYSHORE HIGHWAY STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: THERAVANCE INC DATE OF NAME CHANGE: 20020207 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 doc1.xml FORM 4 X0306 4 2021-05-21 0 0001080014 Innoviva, Inc. INVA 0001329646 Bickerstaff George 1350 OLD BAYSHORE HIGHWAY, SUITE 400 BURLINGAME CA 94010 1 0 0 0 Common Stock 2021-05-21 4 P 0 10000 12.9670 A 114560 D Common Stock 2021-05-24 4 P 0 10000 13.4619 A 124560 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.9650 to $12.9670, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.24 to $13.54, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price. /s/ George Bickerstaff 2021-05-25